ARTICLE | Company News
Arakis, Bioglan deal
January 22, 2001 8:00 AM UTC
The companies will develop Arakis' AD 177 formulated using BGP's dermal delivery technology to treat psoriasis. BGP will receive exclusive global rights to commercialize the compound and will pay Arak...